Subscribe
Home
Issues
Latest Issue
Issue Archive
Special Issues
Categories
Web Exclusives
Web Exclusive Articles
Webinars
Search ...
Caroline Helwick
Authored Items
Can Some Patients with Multiple Sclerosis Stop Treatment?
Caroline Helwick
Multiple Sclerosis
Web Exclusives
Oral Ozanimod: A Safer Sphingosine-1-Phosphate Receptor Modulator?
Caroline Helwick
Multiple Sclerosis
Web Exclusives
Vitamin D Supplementation Shows Benefits in Multiple Sclerosis, but Questions Remain
Caroline Helwick
Multiple Sclerosis
Web Exclusives
Ocrelizumab Receives Breakthrough Therapy for Progressive Multiple Sclerosis
Caroline Helwick
Multiple Sclerosis
VBCN - April 2016 Volume 3, No 1
Ozanimod Achieves Very Low Relapse Rate in MS
Caroline Helwick
Multiple Sclerosis
VBCN - April 2016 Volume 3, No 1
Stem-Cell Transplantation Shows Promise in Multiple Sclerosis, but Major Concerns Remain
Caroline Helwick
Multiple Sclerosis
VBCN - April 2016 Volume 3, No 1
New Dementia Quality Measures Issued by 5 Professional Organizations
Caroline Helwick
Alzheimer’s Disease/Dementia
VBCN - April 2014 Volume 1, No 1
Growing Understanding of Genetic Causes of Progressive Myoclonic Epilepsies Improves the Diagnostic Workup
Caroline Helwick
Personalized Medicine in Neurology
VBCN - April 2014 Volume 1, No 1
AAN Updated Its Guidelines for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation
Caroline Helwick
Stroke
VBCN - April 2014 Volume 1, No 1
Search ...
Home
Issues
Latest Issue
Issue Archive
Special Issues
Categories
Web Exclusives
Web Exclusive Articles
Webinars
Subscribe to
Value-Based Care in Neurology
Stay up to date with personalized medicine by subscribing to recieve the free
VBCN
e‑Newsletter.
I'd like to recieve:
VBCN
e‑Newsletter
I have reviewed and consent to the terms of
VBCN
's
Privacy Policy
, and
VBCN
has my permission to retain my information in its database, and to forward pertinent communications to me.
